Photocure ASA: Results for the third quarter of 2020
Oslo, Norway, 10 November 2020: Photocure ASA (OSE:PHO) today reported Hexvix[®]/Cysview[®] revenues of NOK 49.6 million in the third quarter of 2020 (Q3 2019: NOK 51.1), with the U.S. market continuing the Covid-19 rebound with a growth of 20%. Photocure has successfully launched the European Hexvix operations and reiterates the strong outlook and 2023 ambitions.President & CEO Daniel Schneider comments: “The important U.S. market continued to rebound in the third quarter with a 17% increase in YOY unit sales as fewer procedures were postponed and business disruptions eased. We have